Different inflammatory response and oxidative stress in neointimal hyperplasia after balloon angioplasty and stent implantation in cholesterol-fed rabbits

Pathology Research and Practice

Volumn 202, Issue 6, 2006, Pages 447-456

  Kawamoto, Riichirou ^a   Yamashita, Atsushi ^b   Nishihira, Kensaku ^a   Furukoji, Eiji ^b   Hatakeyama, Kinta ^b   Ishikawa, Tetsunori ^a   Imamura, Takuroh ^a   Itabe, Hiroyuki ^c   Eto, Tanenao ^a   Asada, Yujiro ^b  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b UNIVERSITY OF MIYAZAKI   (Japan)

^c SHOWA UNIVERSITY   (Japan)

Author keywords

Balloon angioplasty; CRP; Oxidative stress; Restenosis; Stents

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; LIPID PEROXIDE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MESSENGER RNA; OXIDIZED PHOSPHATIDYLCHOLINE; PHOSPHATIDYLCHOLINE; PROBUCOL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANGIOGRAPHY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTERY INTIMA PROLIFERATION; ARTERY OCCLUSION; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL INTAKE; CONTROLLED STUDY; GENE EXPRESSION; HYPERLIPIDEMIA; ILIAC ARTERY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFLAMMATION; LIVER PARENCHYMA; MACROPHAGE; MALE; NONHUMAN; OXIDATIVE STRESS; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; RABBIT; STENT; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 33646528012     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2005.12.011     Document Type: Article

References (45)

1. Abe N., Osanai T., Fujiwara T., Kameda K., Matsunaga T., and Okumura K. C-reactive protein-induced upregulation of extracellular matrix metalloproteinase inducer in macrophages: inhibitory effect of fluvastatin. Life Sci. 78 (2006) 1021-1028
2. Angioi M., Abdelmouttaleb I., Rodriguez R.M., Aimone-Gastin I., Adjalla C., Gueant J.L., and Danchin N. Increased C-reactive protein levels in patients with in-stent restenosis and its implications. Am. J. Cardiol. 87 (2001) 1189-1193
3. Azevedo L.C.P., Pedro M.A., Souza L.C., de Souza H.P., Janiszewski M., da Luz P.L., and Laurindo F.R.M. Oxidative stress as a signaling mechanism of the vascular response to injury: the redox hypothesis of restenosis. Cardiovasc. Res. 47 (2000) 436-445
4. Babapulle M.N., Joseph L., Belisle P., Brophy J.M., and Eisenberg M.J. A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents. Lancet 364 (2004) 583-591
5. Berliner J.A., Territo M.C., Sevanian A., Ramin S., Kim J.A., Bamshad B., Esterson M., and Fogelman A.M. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J. Clin. Invest. 85 (1990) 1260-1266
6. Buffon A., Liuzzo G., Biasucci L.M., Pasqualetti P., Ramazzotti V., Rebuzzi A.G., Crea F., and Maseri A. Preprocedural serum levels of C-reactive protein predict early complications and late restenosis after coronary angioplasty. J. Am. Coll. Cardiol. 34 (1999) 1512-1521
7. Cote G., Tardif J.C., Lesperance J., Lambert J., Bourassa M., Bonan R., Gosselin G., Joyal M., Tanguay J.F., Nattel S., Gallo R., and Crepeau J. Effects of probucol on vascular remodeling after coronary angioplasty. Multivitamins and Probucol Study Group. Circulation 99 (1999) 30-35
8. Daida H., Kuwabara Y., Yokoi H., Nishikawa H., Takatsu F., Nakata Y., Kutsumi Y., Ohshima S., Nishiyama S., Ishiwata S., Kato K., Nishimura S., Miyauchi K., Kanoh T., and Yamaguchi H. Effect of probucol on repeat revascularization rate after percutaneous transluminal coronary angioplasty (from the Probucol Angioplasty Restenosis Trial [PART]). Am. J. Cardiol. 86 (2000) 550-552
9. Farb A., Sangiorgi G., Carter A.J., Walley V.M., Edwards W.D., Schwartz R.S., and Virmani R. Pathology of acute and chronic coronary stenting in humans. Circulation 99 (1999) 44-52
10. Farb A., Weber D.K., Kolodgie F.D., Burke A.P., and Virmani R. Morphological predictors of restenosis after coronary stenting in humans. Circulation 105 (2002) 2974-2980
11. Ferns G.A.A., Forster L., Stewart-Lee A., Konneh M., Nourooz-Zadeh J., and Anggard E.E. Probucol inhibits neointimal thickening and macrophage accumulation after balloon injury in the cholesterol-fed rabbit. Proc. Natl. Acad. Sci. USA 89 (1992) 11312-11316
12. Frederick G.P., and Rogers C. Inflammation and restenosis in the stent era. Arterioscler. Thromb. Vasc. Biol. 22 (2002) 1769-1776
13. Griendling K.K., and FitzGerald G.A. Oxidative stress and cardiovascular injury: Part I: Basic mechanisms and in vivo monitoring of ROS. Circulation 108 (2003) 1912-1916
14. Hattori Y., Matsumura M., and Kasai K. Vascular smooth muscle cell activation by C-reactive protein. Cardiovasc. Res. 58 (2003) 186-195
15. Horvath C., Welt F.G.P., Nedelman M., Rao P., and Rogers C. Targeting CCR2 or CD18 inhibits experimental in-stent restenosis in primates: inhibitory potential depends on type of injury and leukocytes targeted. Circ. Res. 90 (2002) 488-494
16. Inoue K., Cynshi O., Kawabe Y., Nakamura M., Miyauchi K., Kimura T., Daida H., Hamakubo T., Yamaguchi H., and Kodama T. Effect of BO-653 and probucol on c-MYC and PDGF-A messenger RNA of the iliac artery after balloon denudation in cholesterol-fed rabbits. Atherosclerosis 161 (2002) 353-363
17. Ishikawa T., Hatakeyama K., Imamura T., Date H., Shibata Y., Hikichi Y., Asada Y., and Eto T. Involvement of C-reactive protein obtained by directional coronary atherectomy in plaque instability and developing restenosis in patients with stable or unstable angina pectoris. Am. J. Cardiol. 91 (2003) 287-292
18. Ishikawa T., Imamura T., Hatakeyama K., Date H., Nagoshi T., Kawamoto R., Matsuyama A., Asada Y., and Eto T. Possible contribution of C-reactive protein within coronary plaque to increasing its own plasma levels across coronary circulation. Am. J. Cardiol. 93 (2004) 611-614
19. Itabe H., Takeshima E., Iwasaki H., Kimura J., Yoshida Y., Imanaka T., and Takano T. A monoclonal antibody against oxidized lipoprotein recognizes foam cells in atherosclerotic lesions: complex formation of oxidized phosphatidylcholines and polypeptides. J. Biol. Chem. 269 (1994) 15274-15279
20. Janiszewski M., Pasqualucci C.A., Souza L.C., Pileggi F., da Luz P.L., and Laurindo F.R.M. Oxidized thiols markedly amplify the vascular response to balloon injury in rabbits through a redox active metal-dependent pathway. Cardiovasc. Res. 39 (1998) 327-338
21. Kawamoto R., Hatakeyama K., Imamura T., Ishikawa T., Date H., Shibata Y., Takenaga M., Asada Y., and Eto T. Relation of C-reactive protein to restenosis after coronary stent implantation and to restenosis after coronary atherectomy. Am. J. Cardiol. 94 (2004) 104-107
22. Kisanuki A., Asada Y., Hatakeyama K., Hayashi T., and Sumiyoshi A. Contribution of the endothelium to intimal thickening in noromocholesterolemic and hypercholesterolemic rabbits. Arterioscler. Thromb. 12 (1992) 1198-1205
23. Kobayashi S., Inoue N., Ohashi Y., Terashima M., Matsui K., Mori T., Fujita H., Awano K., Kobayashi K., Azumi H., Ejiri J., Hirata K., Kawashima S., Hayashi Y., Yokozaki H., Itoh H., and Yokoyama M. Interaction of oxidative stress and inflammatory response in coronary plaque instability: important role of C-reactive protein. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 1398-1404
24. Leitinger N. Oxidized phospholipids as modulators of inflammation in atherosclerosis. Curr. Opin. Lipidol. 14 (2003) 421-430
25. Mold C., Gewurz H., and Du Clos T.W. Regulation of complement activation by C-reactive protein. Immunopharmacology 42 (1999) 23-30
26. Moreno P.R., Bernardi V.H., Lopez-Cuellar J., Newell J.B., McMellon C., Gold H.K., Palacios I.F., Fuster V., and Fallon J.T. Macrophage infiltration predicts restenosis after coronary intervention in patients with unstable angina. Circulation 94 (1996) 3098-3102
27. Mori E., Komori K., Yamaoka T., Tanii K., Kataoka C., Takeshita A., Usui M., Egashira K., and Sugiyama K. essential role of monocyte chemoattractant protein-1 in development of restenotic change (neointimal hyperplasia and constrictive remodeling) after balloon angioplasty in hypercholesterolemic rabbits. Circulation 105 (2002) 2905-2910
28. Nakatani M., Takeyama Y., Shibata M., Yorozuya M., Suzuki H., Koba S., and Katagiri T. Mechanisms of restenosis after coronary intervention: difference between plain old balloon angioplasty and stenting. Cardiovasc. Pathol. 12 (2003) 40-48
29. Oshima R., Ikeda T., Watanabe K., Itakura H., and Sugiyama N. Probucol treatment attenuates the aortic atherosclerosis in Watanabe heritable hyperlipidemic rabbits. Atherosclerosis 137 (1998) 13-22
30. Patti G., Di Sciascio G., D'Ambrosio A., Dicuonzo G., Abbate A., and Dobrina A. Inflammatory markers and coronary interventions: a potentially useful follow-up modality after stenting. Catheter Cardiovasc. Interv. 56 (2002) 341-345
31. Post M.J., de Smet B.J., van der Helm Y., Borst C., and Kuntz R.E. Arterial remodeling after balloon angioplasty or stenting in an atherosclerotic experimental model. Circulation 96 (1997) 996-1003
32. Ridker P.M. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 103 (2001) 1813-1818
33. Rogers C., and Edelman E.R. Endovascular stent design dictates experimental restenosis and thrombosis. Circulation 91 (1995) 2995-3001
34. Rogers C., Welt F.G.P., Karnovsky M.J., and Edelman E.R. Monocyte recruitment and neointimal hyperplasia in rabbits: coupled inhibitory effects of heparin. Arterioscler. Thromb. Vasc. Biol. 16 (1996) 1312-1318
35. Rogers C., Edelman E.R., and Siomon D.I. A mAb to the beta2-leukocyte integrin Mac-1 (CD11b/CD18) reduces intimal thickening after angioplasty or stent implantation in rabbits. Proc. Natl. Acad. Sci. USA 95 (1998) 10134-10139
36. Ross R. Atherosclerosis-an inflammatory disease. N. Engl. J. Med. 340 (1999) 115-126
37. Sun H., Koike T., Ichikawa T., Hatakeyama K., Shiomi M., Zhang B., Kitajima S., Morimoto M., Watanabe T., Asada Y., Chen Y.E., and Fan J. C-reactive protein in atherosclerotic lesions: its origin and pathophysiological significance. Am. J. Pathol. 167 (2005) 1139-1148
38. Szocs K., Lassegue B., Sorescu D., Hilenski L.L., Valppu L., Couse T.L., Wilcox J.N., Quinn M.T., Lambeth J.D., and Griendling K.K. Upregulation of Nox-based NAD(P)H oxidases in restenosis after carotid injury. Arterioscler. Thromb. Vasc. Biol. 22 (2002) 21-27
39. Tardif J.C., Gregoire J., Schwartz L., Title L., Laramee L., Reeves F., Lesperance J., Bourassa M.G., L'Allier P.L., Glass M., Lambert J., and Guertin M.C. Effects of AGI-1067 and probucol after percutaneous coronary interventions. Circulation 107 (2003) 552-558
40. Verma S., Li S.H., Badiwala M.V., Weisel R.D., Fedak P.W.M., Li R.K., Dhillon B., and Mickle D.A.G. Endothelial antagonism and interleukin-6 inhibition attenuate the proatherogenic effect of C-reactive protein. Circulation 105 (2002) 1890-1896
41. Watanabe K., Sekiya M., Ikeda S., Miyagawa M., and Hashida K. Preventive effects of probucol on restenosis after percutaneous transluminal coronary angioplasty. Am. Heart J. 132 (1996) 23-29
42. Williams T.N., Zhang C.X., Game B.A., He L., and Huang Y. C-reactive protein stimulates MMP-1 expression in U937 histiocytes through Fc[gamma]RII and extracellular signal-regulated kinase pathway: an implication of CRP involvement in plaque destabilization. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 61-66
43. Yasojima K., Schwab C., McGeer E.G., and McGeer P.L. Generation of C-reactive protein and complement components in atherosclerotic plaques. Am. J. Pathol. 158 (2001) 1039-1051
44. Yokoi H., Daida H., Kuwabara Y., Nishikawa H., Takatsu F., Tomihara H., Nakata Y., Kutsumi Y., Ohshima S., Nishiyama S., Seki A., Kato K., Nishimura S., Kanoh T., and Yamaguchi H. Effectiveness of an antioxidant in preventing restenosis after percutaneous transluminal coronary angioplasty: the Probucol Angioplasty Restenosis Trial. J. Am. Coll. Cardiol. 30 (1997) 855-862
45. Zwaka T.P., Hombach V., and Torzewski J. C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis. Circulation 103 (2001) 1194-1197